Liver function in horses encompasses a range of physiological processes essential for maintaining homeostasis. The liver is responsible for various metabolic, detoxification, and synthetic activities, including the metabolism of carbohydrates, proteins, and fats, as well as the detoxification of endogenous and exogenous substances. It also synthesizes proteins such as albumin and clotting factors, and produces bile necessary for digestion. Liver function can be assessed through biochemical tests that measure enzyme activities and metabolite levels in the blood. This page compiles peer-reviewed research studies and scholarly articles that explore the mechanisms, assessment, and clinical implications of liver function in equine health.
Pires MJ, Cotovio M, Queiroga F, Pires CA, Silvestre-Ferreira AC.To date, serum biochemical analytes reference intervals (RIs) in Lusitano horses have not been studied. This study aimed to establish the RIs for biochemical analytes following the American Society of Veterinary Clinical Pathology guidelines and to compare them with the general equine population's RIs. Blood samples were collected from 76 clinically healthy adult Lusitano horses, and RIs of 22 biochemical variables were determined using Reference Value Advisor software. Lusitano horse-specific RIs are proposed for the following variables: total protein (3.9-7.0 g/dL), albumin (2.5-3.8 g/dL), g...
Michanek P, Bröjer J, Lilliehöök I, Fjordbakk C, Erkas M, Löwgren M, Hedeland M, Bergquist J, Ekstrand C.Sodium-glucose co-transporter 2 inhibitors like canagliflozin (CFZ) have shown promise in preventing hyperinsulinemia-associated laminitis in horses, but data on pharmacokinetics, tolerability, and controlled studies are limited. This randomized, open-label, placebo-controlled, crossover study evaluated these aspects of CFZ treatment in eight healthy Standardbred mares. Each horse received single supratherapeutic oral doses of CFZ (1.8 mg/kg or 3.6 mg/kg) and placebo, with a two-week washout between treatments. A graded glucose infusion (GGI) was administered post-treatment to evaluate glu...
Macias A, Delvescovo B, Donaldson SF, Divers TJ, Donnelly CG.Ursodeoxycholic acid (UDCA), a secondary bile acid (BA) with therapeutic applications, is standard therapy for cholestatic hepatopathies in humans. In recent years, its use has been increasingly explored in equine medicine for similar indications. Pharmacokinetic data for UDCA in horses are currently lacking. This study aimed to describe the pharmacokinetic parameters following a single intragastric administration of 15 mg/kg in nine healthy, fasted horses and to characterize the changes in their BA profiles. Plasma concentrations of UDCA were measured at specific time points using liquid ch...
